NCT01060735

Brief Summary

Vitamin D deficiency is frequently reported in pregnant women despite recommendation of daily vitamin D supplementation of 400IU/d. Recent studies have shown that in the absence of sun exposure these doses are seldom able to achieve 25(OH)D optimal serum levels. We hypothesize that larger doses of vitamin D are needed to be supplemented to all women during pregnancy. We hypothesize that this may have advantageous effects on maternal vitamin D and bone reserve as well on offspring vitamin D and bone status at birth and possible further on. The aim of the present study is to compare vitamin D and bone status of infants born to mothers supplemented with 400IU/d (present recommendations) and 2000IU/d vitamin D during the third trimester of pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Nov 2010

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 2, 2010

Completed
9 months until next milestone

Study Start

First participant enrolled

November 1, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

July 22, 2011

Status Verified

July 1, 2011

Enrollment Period

1.9 years

First QC Date

January 31, 2010

Last Update Submit

July 21, 2011

Conditions

Keywords

Vitamin Dpregnancychildrenbonequantitative ultrasoundHealthy pregnant women

Outcome Measures

Primary Outcomes (1)

  • Bone status in offspring at the age of one year as assessed by tibial and radius quantitative ultrasound (QUS).

    Bone status in offsprings, assessed at the age of one year

Secondary Outcomes (5)

  • Vitamin D status of mothers.

    At the start of intervention, at delivery and at the age of one year

  • Maternal health status.

    At the start of intervention, at delivery and at the age of one year

  • Infants' growth.

    At the start of intervention, at delivery and at the age of one year

  • Vitamin D status in infants.

    At the start of intervention, at delivery and at the age of one year

  • Safety of vitamin D supplementation doses.

    At the start of intervention, at delivery and at the age of one year

Study Arms (2)

Larger doses of vitamin D supplementation

EXPERIMENTAL

The subjects enrolled in this arm will be supplemented during the third trimester of pregnancy with 2000IU vitamin D per day

Dietary Supplement: Vitamin D

Conventional vitamin D supplementation

NO INTERVENTION

Regular supplementation during pregnancy with 400IU vitamin D

Interventions

Vitamin DDIETARY_SUPPLEMENT

Vitamin D 2000iu/ day from the 27 week of pregnancy up to delivery

Larger doses of vitamin D supplementation

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy pregnant women aged 20 to 40 years, of any parity status.
  • Signed informed consent

You may not qualify if:

  • Presence of diseases known to affect vitamin D status such as malabsorption states, liver and renal disorders, primary and tertiary hyperparathyroidism, granulomatous disorders
  • Treatment with medications known to affect vitamin D status such as anticonvulsivants, glucocorticoids, antirejection medication and retroviral agents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schneider Children's Medical Center of Israel

Petah Tikva, 49202, Israel

RECRUITING

MeSH Terms

Interventions

Vitamin D

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Officials

  • Corina Hartman, MD

    Rabin Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Corina Hartman, MD

CONTACT

Raanan Shamir, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 31, 2010

First Posted

February 2, 2010

Study Start

November 1, 2010

Primary Completion

October 1, 2012

Study Completion

December 1, 2013

Last Updated

July 22, 2011

Record last verified: 2011-07

Locations